These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 21981267)
41. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. Gluckman E; Rocha V; Boyer-Chammard A; Locatelli F; Arcese W; Pasquini R; Ortega J; Souillet G; Ferreira E; Laporte JP; Fernandez M; Chastang C N Engl J Med; 1997 Aug; 337(6):373-81. PubMed ID: 9241126 [TBL] [Abstract][Full Text] [Related]
42. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders. Kwon M; Balsalobre P; Serrano D; Pérez Corral A; Buño I; Anguita J; Gayoso J; Diez-Martin JL Biol Blood Marrow Transplant; 2013 Jan; 19(1):143-9. PubMed ID: 22960386 [TBL] [Abstract][Full Text] [Related]
43. Dendritic cell count in the graft predicts relapse in patients with hematologic malignancies undergoing an HLA-matched related allogeneic peripheral blood stem cell transplant. Rajasekar R; Lakshmi KM; George B; Viswabandya A; Thirugnanam R; Abraham A; Chandy M; Srivastava A; Mathews V Biol Blood Marrow Transplant; 2010 Jun; 16(6):854-60. PubMed ID: 20138229 [TBL] [Abstract][Full Text] [Related]
44. Ten years of cord blood transplantation: from bench to bedside. Gluckman E Br J Haematol; 2009 Oct; 147(2):192-9. PubMed ID: 19796268 [TBL] [Abstract][Full Text] [Related]
45. Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia. Sanz J; Montesinos P; Saavedra S; Lorenzo I; Senent L; Planelles D; Larrea L; Martín G; Palau J; Jarque I; Martínez J; de la Rubia J; Moscardó F; Martinez D; Gómez I; López M; Sanz MA; Sanz GF Biol Blood Marrow Transplant; 2010 Nov; 16(11):1589-95. PubMed ID: 20553927 [TBL] [Abstract][Full Text] [Related]
46. Allogeneic peripheral blood stem cell transplantations in children--a single center experience. Sufliarska S; Horáková J; Bodová I; Martinka J; Hrubisko M; Kovács L; Jancovicová K; Lukác J Neoplasma; 2004; 51(2):110-6. PubMed ID: 15190420 [TBL] [Abstract][Full Text] [Related]
47. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Martin PL; Carter SL; Kernan NA; Sahdev I; Wall D; Pietryga D; Wagner JE; Kurtzberg J Biol Blood Marrow Transplant; 2006 Feb; 12(2):184-94. PubMed ID: 16443516 [TBL] [Abstract][Full Text] [Related]
48. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation. Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680 [TBL] [Abstract][Full Text] [Related]
49. Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units. Yin Y; Ren HY; Cen XA; Qiu ZX; Ou JP; Wang WS; Wang MJ; Xu WL; Wang LH; Li Y; Dong YJ Chin Med J (Engl); 2011 Aug; 124(16):2411-6. PubMed ID: 21933579 [TBL] [Abstract][Full Text] [Related]
50. Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry. Wallet HL; Sobh M; Morisset S; Robin M; Fegueux N; Fürst S; Mohty M; Deconinck E; Fouillard L; Bordigoni P; Rio B; Sirvent A; Renaud M; Dhedin N; Tabrizi R; Maury S; Buzyn A; Michel G; Maillard N; Cahn JY; Bay JO; Yakoub-Agha I; Huynh A; Schmidt-Tanguy A; Lamy T; Lioure B; Raus N; Marry E; Garnier F; Balère ML; Gluckman E; Rocha V; Socié G; Blaise D; Milpied N; Michallet M Exp Hematol; 2013 Nov; 41(11):924-33. PubMed ID: 23831606 [TBL] [Abstract][Full Text] [Related]
52. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF; Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063 [TBL] [Abstract][Full Text] [Related]
53. Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia. Ayas M; Al-Seraihi A; Al-Jefri A; Al-Ahmari A; Al-Mahr M; Al-Ghonaium A; Al-Muhsen S; Al-Mousa H; Al-Dhekri H; Alsaud B; Eldali A; Mohamad A; Al-Humaidan H; Chadrawi A; Al-Kaff M; Al-Hassnan Z; El-Solh H Bone Marrow Transplant; 2010 Aug; 45(8):1281-6. PubMed ID: 20010867 [TBL] [Abstract][Full Text] [Related]
54. Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease. Park M; Lee SH; Lee YH; Yoo KH; Sung KW; Koo HH; Kang HJ; Park KD; Shin HY; Ahn HS; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Han DK; Baek HJ; Kook H; Hwang TJ; Lee EK; Hah JO; Lim YJ; Jung HJ; Park JE; Jang MJ; Chong SY; Oh D; Biol Blood Marrow Transplant; 2013 Apr; 19(4):640-6. PubMed ID: 23380345 [TBL] [Abstract][Full Text] [Related]
55. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome. Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P; Escolar M; Gluckman E; Cavazzana-Calvo M; Kurtzberg J; Biol Blood Marrow Transplant; 2009 May; 15(5):618-25. PubMed ID: 19361754 [TBL] [Abstract][Full Text] [Related]
56. Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank. Ballen KK; Haley NR; Kurtzberg J; Lane TA; Lindgren BR; Miller JP; Newman B; McCullough J Transfusion; 2006 Dec; 46(12):2063-70. PubMed ID: 17176317 [TBL] [Abstract][Full Text] [Related]
57. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bradley MB; Satwani P; Baldinger L; Morris E; van de Ven C; Del Toro G; Garvin J; George D; Bhatia M; Roman E; Baxter-Lowe LA; Schwartz J; Qualter E; Hawks R; Wolownik K; Foley S; Militano O; Leclere J; Cheung YK; Cairo MS Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841 [TBL] [Abstract][Full Text] [Related]
58. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449 [TBL] [Abstract][Full Text] [Related]
59. Unrelated umbilical cord blood transplantation in children: experience of the Hong Kong Red Cross Blood Transfusion Service. Li CK; Shing MM; Chik KW; Tsang KS; Tang NL; Chan PK; Chan NK; Lee V; Ng MH; Lin CK; Yuen PM Hong Kong Med J; 2004 Apr; 10(2):89-95. PubMed ID: 15075428 [TBL] [Abstract][Full Text] [Related]
60. Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience. Bacigalupo A; Zikos P; Van Lint MT; Valbonesi M; Lamparelli T; Gualandi F; Occhini D; Mordini N; Bregante S; Berisso G; Vitale V; Sessarego M; Marmont AM Exp Hematol; 1998 May; 26(5):409-14. PubMed ID: 9590657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]